However, differences between active treatment groups did not reach statistical significance.
← all excerpts
Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy.
1
—
—
However, differences between active treatment groups did not reach statistical significance.